1997 Annual Report
Product Review Financials Setting  
  | Product Pipeline      
| Product Portfolio

| Cardiovascular Diseases | Central Nervous System Disorders | Infectious Diseases |
| Arthritis/Inflammation | Metabolic Diseases | Allergic Diseases |
| Cancer | Genitourinary/Sexual Health | Surgery/Interventional |
| Consumer Health/OTC | Animal Health |
 

MAJOR PFIZER PRODUCTS AND SELECTED CANDIDATES IN DEVELOPMENT
Consumer Health/OTC
Current Products
Aludrox [I]
Analock [I]
Aneton [I]
Antiminth [U.S.]
Aquasun [I]
Atarax-P [I]
Bain de Soleil
Banlice [I]
Barbasol/Pure Silk
BenGay
Bonine/Bonamine [I]
Buttercup [I]
Choats [I]
Combantrin [I]
Corex [I]
Cortizone
Dabaways [I]

DentSure [U.S.]
Desitin/Daily Care [U.S.]
Diflucan One
(OTC) [I]
Feldene Gel
(OTC) [I]
Galaflex [I]
Galloways [I]
GyneCure [I]
Hemorid
Isogel [I]
Juscoat [I]
Liqufruta [I]
Lucilla [I]
Migraleve [I]
OcuHist [U.S.]
Ondaflex [I]
Pacquin
Plax [U.S.]

PLT [I]
Rappell [I]
Reactine (OTC) [I]
Rectinol [I]
Rheaban [U.S.]
Rid
Stoppers [I]
Straitus [I]
Taizer [I]
Terra-Cortril [I]
Terramycin [I]
TCP [I]
Trosyd AF [I]
Unisom
Vanart
Visine/Visaclean
Wart-Off

Extensions / Additional Indications (last 12 months) Under Regulatory Review In Advanced-Stage Development
Advanced Relief Visine
Desitin Creamy

BenGay
Desitin
Feldene Topical
OcuHist
Unisom

(in process of registration in various international markets)
Key: [U.S.]—U.S. only    [I]—International only (in at least one country)
No Key—Both U.S. and at least one other country

  letter back top next
  Logo Imagemap
  intended for investors
  Advisory Information for Investors
  Copyright © 1997, 1998 Pfizer Inc All rights reserved.